The southern cattle tick (Rhipicephalus (Boophilus) microplus) is a hematophagous external parasite that vectors the causative agents of bovine babesiosis or cattle tick fever, Babesia bovis and B. bigemina, and anaplasmosis, Anaplasma marginale. The southern cattle tick is a threat to the livestock industry in many locations throughout the world. Control methods include the use of chemical acaricides including amitraz, a formamidine insecticide, which is proposed to activate octopamine receptors. Previous studies have identified a putative octopamine receptor from the southern cattle tick in Australia and the Americas. Furthermore, this putative octopamine receptor could play a role in acaricide resistance to amitraz. Recently, sequence data indicated that this putative octopamine receptor is probably a type-1 tyramine receptor (TAR1). In this study, the putative TAR1 was heterologously expressed in Chinese hamster ovary (CHO-K1) cells, and the expressed receptor resulted in a 39-fold higher potency for tyramine compared to octopamine. Furthermore, the expressed receptor was strongly antagonized by yohimbine and cyproheptadine, and mildly antagonized by mianserin and phentolamine. Tolazoline and naphazoline had agonistic or modulatory activity against the expressed receptor, as did the amitraz metabolite, BTS-27271; however, this was only observed in the presence of tyramine. The southern cattle tick's tyramine receptor may serve as a target for the development of anti-parasitic compounds, in addition to being a likely target of formamidine insecticides. 
a b s t r a c t
The southern cattle tick (Rhipicephalus (Boophilus) microplus) is a hematophagous external parasite that vectors the causative agents of bovine babesiosis or cattle tick fever, Babesia bovis and B. bigemina, and anaplasmosis, Anaplasma marginale. The southern cattle tick is a threat to the livestock industry in many locations throughout the world. Control methods include the use of chemical acaricides including amitraz, a formamidine insecticide, which is proposed to activate octopamine receptors. Previous studies have identified a putative octopamine receptor from the southern cattle tick in Australia and the Americas. Furthermore, this putative octopamine receptor could play a role in acaricide resistance to amitraz. Recently, sequence data indicated that this putative octopamine receptor is probably a type-1 tyramine receptor (TAR1). In this study, the putative TAR1 was heterologously expressed in Chinese hamster ovary (CHO-K1) cells, and the expressed receptor resulted in a 39-fold higher potency for tyramine compared to octopamine. Furthermore, the expressed receptor was strongly antagonized by yohimbine and cyproheptadine, and mildly antagonized by mianserin and phentolamine. Tolazoline and naphazoline had agonistic or modulatory activity against the expressed receptor, as did the amitraz metabolite, BTS-27271; however, this was only observed in the presence of tyramine. The southern cattle tick's tyramine receptor may serve as a target for the development of anti-parasitic compounds, in addition to being a likely target of formamidine insecticides.
© 2015 Elsevier Ltd. All rights reserved.
Introduction
The southern cattle tick (Rhipicephalus (Boophilus) microplus) is an ectoparasite that can have an economically devastating effect on the cattle industry worldwide (Grisi et al., 2014) . R. microplus, in the United States, was estimated to have direct costs of more than $130 million to the cattle industry in 1906, which has been estimated to be over $3 billion today (USDA-APHIS August 2010). The significant economic impact of this tick is realized with the diseases that it is capable of vectoring. Specifically, the southern cattle tick is capable of vectoring the apicomplexan protozoa Babesia bovis and B. bigemina, which cause bovine babesiosis, and the rickettsia Anaplasma marginale that causes anaplasmosis (P erez de Le on et al., 2012; P erez de .
The United States initiated the Cattle Fever Tick Eradication Program (CFTEP) in 1906, which eliminated the southern cattle tick (R. microplus) and the cattle fever tick (R. annulatus) from thirteen southern states by 1941 (P erez de . The mainstay of the CFTEP is the use of chemical acaricides; specifically, the organophosphate coumaphos. However, internationally several chemical acaricides, with different mechanisms of action, have been used to control the southern cattle tick, and has predictably resulted in acaricide resistance. Acaricide resistance, particularly with tick strains found in the Americas, has been reported for several chemical classes including organophosphates (Miller et al., 2005; RodriguezVivas et al., 2007; Temeyer et al., 2007; Miller et al., 2008; Guerrero et al., 2012) , synthetic pyrethroids (Li et al., 2007; Miller et al., 2007a; Cossio-Bayugar et al., 2008; Guerrero and Nene, 2008; Rosario-Cruz et al., 2009 ) and formamidines (Li et al., 2007; Miller et al., 2007b; Corley et al., 2013) . Recently, a population of R. microplus of concern has been discovered in Mexico. This population is resistant to synthetic pyrethroids, organophosphates, amitraz (formamidine) and ivermectin (macrocyclic lactone family) (Fernandez-Salas et al., 2012) . The permanent quarantine zone in south Texas along the TexaseMexico border is part of the continued effort by the CFTEP to keep the U.S. free of cattle fever ticks and bovine babesiosis. As R. microplus is endemic to Mexico, there is the possibility of regular reintroduction of the southern cattle tick into the U.S. Reintroduction is possible with the movement of cattle into the U.S. from Mexico and the ability of the tick to be maintained on wild ungulates. For continued success of the CFTEP, it is imperative that integrative pest control measures are taken, that new biochemical targets for tick control are identified and a greater understanding of the mechanism(s) of acaricide resistance (Temeyer et al., 2012; P erez de Le on et al., 2012; Guerrero et al., 2014) .
Octopamine and tyramine are biogenic amines found in a many of invertebrates, including insects and ticks, and have been shown to be involved in different physiological functions in insects. These physiological functions are realized when octopamine or tyramine activates their cognate receptor, which are G-protein-couple receptors (GPCRs) (Guerrero and Dowd, 2010) . Octopamine and tyramine are characterized as neurotransmitters, neurohormones and neuromodulators (Roeder et al., 2003; Roeder, 2005; Farooqui, 2012; Ohta and Ozoe, 2014) . While the diverse physiological functions of octopamine have been realized for some time, we are only starting to understand the physiological relevance of tyramine; this is because, until recently, tyramine was thought to only be a synthetic precursor to octopamine (Guerrero and Dowd, 2010; Roeder et al., 2003; Roeder, 2005; Verlinden et al., 2010; Farooqui, 2012) . Octopamine receptors are believed to be the target of formamidine insecticides/acaricides, which include chlordimeform and amitraz (Blenau et al., 2012; Hashemzadeh et al., 1985) . Hyperactivity and tick detachment are symptoms of exposure to sublethal concentrations of formamidine acaricides against the southern cattle tick (Stone et al., 1974) .
A cDNA sequence (AJ010743.1), originally thought to code for an octopamine receptor, was isolated from two strains of R. microplus ticks that were susceptible and resistant to amitraz in Australia. However, the identified open reading frame (ORF) did not result in any point mutations (Baxter and Barker, 1999) . The putative octopamine receptor was later identified in tick populations from the Americas (EF490687.1 and EF490688.1) . Additionally, two point mutations, T8P and L22S, were identified in this putative receptor's open reading frame obtained from amitrazresistant ticks (EF490688.1). These point mutations were hypothesized to have a possible role in the resistance to the acaricide amitraz . However, the functional identification of these receptors ligands has yet to be performed. In fact, it has been hypothesized, based on sequence similarity, that the originally identified receptor is a tyramine receptor, instead of an octopamine receptor (Verlinden et al., 2010; Farooqui, 2012) . The objectives of this study were to (1) functionally characterize the putative tyramine receptor from the southern cattle tick, and (2) determine the receptor pharmacology using functional assays.
Materials and methods

Chemicals
Pharmacological analysis was performed with compounds purchased from SigmaeAldrich (St. Louis, MO) unless otherwise noted. Test compounds include tyramine hydrochloride (!98%), DL- octopamine hydrochloride (99%), (±)-synephrine, dopamine hydrochloride (!98.5%), DL-norepinephrine hydrochloride (!97%), serotonin hydrochloride (5-hydroxytryptamine, 5-HT), (±)-epinephrine hydrochloride, histamine dihydrochloride (!99%), phentolamine hydrochloride (!98%), yohimbine hydrochloride (!98%), clonidine hydrochloride (solid), mianserin hydrochloride, (±)-propranolol hydrochloride (!99%), chlorpromazine hydrochloride (!98%), amitraz metabolite BTS-27271 (N-(2,4-Dimethylphenyl)-N 0 -methylformamidine, N-Methyl-N 0 -2,4-xylylformamidine) Pestanal ® (Fluka), naphazoline hydrochloride, 2-benzylimidazoline (tolazoline). Test compounds were prepared fresh for each testing procedure with the exception of the amitraz metabolite BTS-27271, which was used from frozen DMSO stocks. Tyramine and octopamine were prepared in Hank's Balance Salt Solution (HBSS, Life Technologies, Carlsbad, CA). The remaining compounds were dissolved in DMSO then serially diluted with HBSS. The cells were exposed to a final concentration of 0.1% DMSO.
Putative tyramine receptor
The wild-type putative tyramine receptor (EF490687.1) was isolated from the Gonzalez strain of tick (amitraz-susceptible). The Gonzalez strain of R. microplus was originally identified in Zapata County, Texas in 1984, and has been maintained in culture by the USDA-ARS Knipling-Bushland U.S. Livestock Insects Research Laboratory (KBUSLIRL), Kerrville, TX at the USDA-ARS Cattle Fever Tick Research Laboratory (CFTRL), Edinburg, TX . The receptor cDNA was synthesized by GeneScript USA Inc. (Piscataway, NJ) and cloned into a pCDNA3.1(À) expression vector (Life Technologies).
CHO cell culture, transfection and calcium mobilization assay
Cell culture materials were obtained from Life Technologies, unless otherwise stated. Chinese hamster ovary-K1 (CHO or CHO-K1) cells were obtained from American Type Culture Collection (ATCC; Manassas, VA). CHO cells were maintained in a NuAire humidified water jacket incubator (Plymouth, MN); the incubator was maintained at normal cell growth conditions of 37 C, 90% humidity and 5% CO 2 . The normal cell growth medium consisted of 1X Ham's F12K (Kaighn's modification) medium supplement with 10 mM HEPES (N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid) plus 10% fetal bovine serum (FBS) (Atlas Biologicals, Fort Collins, CO). CHO cells were subcultured when cell confluency reached 80%e90%. To subculture, cells were washed with Dulbecco's Phosphate Buffered Saline (DPBS); then cells were detached from culturing flasks with 0.25% trypsin e 0.53 mM EDTA (trypsin-EDTA) solution. Cells were then centrifuged at 900 Â g for 5 min at room temperature; cell pellet was resuspended in fresh normal cell growth media.
Transient transfection of CHO cells with the putative tyramine receptor was performed in 6-well cell culture plates (Corning). Cells were transfected using Lipofectamine 2000 ® in OPTI-MEM supplement with F12K þ 10% FBS, according to the manufacturer's protocols (Invitrogen). Cells were transfected with 2.5 mg of vector DNA, which allowed the examination of the putative tyramine receptor's ability to link to the endogenous calcium pathway (Ga q ). CHO cells were also transfected with individual G-protein chimeras (Ga qo5 , Ga qi5 , Ga qs5 , or Ga qz5 ) to force receptor-mediated signaling down the calcium-signaling pathway as previously described (Conklin et al., 1996; Omar et al., 2007) . CHO cells were incubated in the transfection medium for 12 h at normal cell growth conditions. After 12 h, cells were lifted from 6-well plate using trypsin-EDTA. Cells were washed with normal growth medium and moved to a 15-mL conical tube, and were centrifuged at 900 Â g at room temperature for 5 min. The cell pellet was resuspended in 3e3.5 mL of normal cell growth medium. CHO cells were counted using a Countess ® Automatic Cell Counter (Life Technologies), according to the manufacturer's protocols. CHO cells were placed into black-wall clear-bottom 96-well plates (Corning) at a cell density of 27,500 cells per well, with a total volume of 100 mL. Cells were incubated at normal cell culture conditions for 24 h prior to performing the calcium mobilization assay. The calcium mobilization assay was performed with a Fluo-4 NW Calcium Assay Kit (Life Technologies), according to the manufacturer's protocol. Briefly, the cells were incubated in HBSS, 20 mM HEPES, a calcium-sensitive fluorescent dye (Fluo-4) and 2.5 mM probenecid; cells were incubated in this medium for 90 min at 37 C prior to the start of the assay. Fluorescence was monitored using a FlexStation 1 (Molecular Devices, Sunnyvale, CA). Fluorescence changes were monitored with excitation at 494 nM and emission at 516 nM. Basal fluorescence was monitored for 20 s prior to the addition of screening compounds. The fluorescence readings were measured every 1.5 s for 120 s. Stable transfection was performed using the transient transfection procedure. However, instead of proceeding to the functional assay, cells were maintained in medium containing 100 mg/mL of Geneticin ® (G418 sulfate; Corning). Single-cell colonies were selected in 96-well plates over four weeks. Successfully transfected cells, with both the putative tyramine receptor and G-protein chimera, were determined with a calcium mobilization assay and by RT-PCR. Compounds were screened using an agonist and/or an antagonist screening method. The agonist screening method was utilized with the addition of the potential agonist added by the FlexStation after a 20-second background reading. Antagonist or modulator screening was performed by preincubating the putative antagonist or modulator with the cells in the black-walled clear-bottom 96-well plate for 30 min prior to the addition of tyramine (addition performed by the FlexStation).
Data analysis
A minimum of six wells per plate along with a minimum of four plates was analyzed for each treatment. Additionally, each plate contained several controls: a blank (calcium fluorescent indicator, probenecid (2.5 mM) and HBSS with 10 mM HEPES buffer), a vehicle control, along with an autofluorescent control (fluorescent indicator (Fluo-4), HBSS with 10 mM HEPES and the ligand). Additionally, non-receptor mediated effects were monitored for each treatment and consisted of untransfected cells not expressing the receptor (regular CHO cells). Concentration-response curves were analyzed in GraphPad Prism (La Jolla, CA). One-way ANOVA and a paired t-test were used to test the data for statistically significant differences of agonist and antagonist compounds using SAS 9.3 (Cary, NC). Student-Newman-Keuls (SNK) post-hoc analysis was used to determine significant differences between treatments with 95% confidence (a ¼ 0.05). Antagonist and modulator screening results were normalized to 150 nM tyramine (100%), which is represented as a dashed line in the appropriate figures.
Results
The putative tyramine receptor was successfully expressed in Chinese Hamster Ovary (CHO) cells, and functional receptor activation was determined using a calcium-liberation assay. The calcium-liberation assay analyzes receptor activation via the Ga q phospholipase-C (PLC) pathway. Receptor activation results in an increase of cytosolic calcium, which can be quantified using a calcium-sensitive fluorescent dye. However, not all receptors will signal using the Ga q PLC pathway; therefore, a set of Ga q -protein chimeras, which funnel receptor activation down the Ga q PLC pathway resulting in an increase of intracellular calcium, were used (Fig. 1) . These G-protein chimeras were developed to have the receptor-interacting domain (5 amino acids) from different G-proteins (Ga s , Ga z , Ga i and Ga o ), built on the Ga q backbone to make a hybrid calcium-sensitive signaling molecule designated as Ga qs (5) , Ga qz(5) , Ga qi(5) and Ga qo(5) . Therefore, heterologous expression of a receptor with the Ga q chimera allows for quantification of receptor activation using a fluorescence output (Fig. 1) .
The R. microplus putative tyramine receptor was transiently expressed in CHO cells alone to see if the receptor activated the endogenous Ga q PLC pathway (Fig. 1) . Expression of the receptor alone resulted in a weak fluorescent response to tyramine and octopamine at 1 mM (Fig. 1) . Transient expression was performed with the putative tyramine receptor in combination with individual Ga q chimeras (Ga qs(5) , Ga qz(5) , Gaq i(5) and Ga qo(5) ). As shown in Fig. 1 , co-expression of the putative tyramine receptor resulted in the most significant response when co-expressed with the Ga qi (5) G-protein chimera (Fig. 1) . Additionally, 1 mM tyramine had a stronger and more significant fluorescence response when compared to 1 mM octopamine, which indicated that tyramine preferentially activated the heterologously expressed receptor with the Ga qi(5) G-protein chimera. Tyramine and octopamine displayed concentration-dependent responses in CHO cells transiently expressing the receptor along with the Ga qi(5) chimeric protein (Fig. 2) . Tyramine had an EC 50 of 9 nM, whereas octopamine had an EC 50 of 351 nM; therefore, tyramine is 39-fold more effective at activating the heterologously expressed receptor with the Ga qi(5) chimera, compared to octopamine (Fig. 2 and Table 1 ). Additional biogenic amines were screened at 1 mM to ensure that tyramine is the preferred ligand. Tyramine activated the receptor most significantly, followed by octopamine. Acetylcholine, along with the Nmethylated analogue of octopamine, synephrine, were capable of mildly activating the expressed receptor and Ga qi(5) chimera, but not as significantly as tyramine or octopamine (Fig. 3) . Dopamine, 5-HT (serotonin), norepinephrine, epinephrine and histamine had little effect against the expressed receptor and chimera at 1 mM (Fig. 3) . These results indicated that the originally classified putative octopamine receptor (referred to here as the putative tyramine receptor) aligns with the proliferation of tyramine receptor sequence data to show the receptor is a tyramine receptor. Specifically, this receptor appears to be a tyramine-1 receptor (RmTAR1) (Ohta and Ozoe, 2014) .
A colonial cell line that stably expressed the cattle tick tyramine receptor and the Ga qi(5) chimera was established and selected over several weeks. Efficiency of the stable transfection of both the tyramine receptor and the G-protein chimera was approximately 8% (n ¼ 24). Tyramine resulted in a concentration-dependent response of CHO cells stably expressing the tyramine receptor and the Ga qi(5) chimera, which had an EC 50 of 15 nM. This is similar to CHO cells transiently expressing the tyramine receptor and the Ga qi(5) chimera (Fig. 4 and Table 1 ).
The pharmacological toolbox to characterize octopamine receptors and tyramine receptors is limited. Adrenergic agonists and adrenergic antagonists are commonly used to determine the pharmacology of octopamine receptors and tyramine receptors. Six antagonists (propranolol, chlorpromazine, mianserin, phentolamine, cyproheptadine and yohimbine) were screened at three concentrations (0.1 mM, 1 mM and 10 mM) to determine if they were capable of antagonizing the receptor when the receptor was stimulated with 150 nM tyramine (Fig. 5) . Propranolol enhanced the effect of 50 nM tyramine, but it was not statistically significant from tyramine alone (Fig. 5 ). Cyproheptadine and yohimbine were the only compounds capable of antagonizing 150 nM of tyramine significantly at all three concentrations (0.1 mM, 1 mM and 10 mM) tested (Fig. 5) . Mianserin antagonized 150 nM of tyramine at 1 mM and 10 mM (Fig. 5) . Phentolamine antagonized only at 10 mM. Yohimbine and phentolamine both antagonized the 1 mM tyramine response in a concentration-dependent manner; however, yohimbine was 18-fold more effective at antagonizing the RmTAR1 compared to phentolamine ( Table 2) .
Compounds that were able to stimulate or act as agonists to the RmTAR1 were also examined. Agonists tested include clonidine, naphazoline and tolazoline, which were screened at 0.1 mM, 1 mM and 10 mM to see if they activated RmTAR1, compared to the same Fig. 2 . Concentration-dependent response of transiently expressed RmTAR1 plus Ga qi(5) . Concentration-dependent response of the expressed coding sequence of the R. microplus tyramine receptor and the Ga qi(5) G-protein chimera with several concentrations of tyramine (solid black line) and octopamine (solid gray line). These two biogenic amines were used to monitor the increase of intracellular calcium, using a calcium-sensitive fluorescent dye, measured by relative fluorescence units (RFU). CHO cells not transfected with the receptor were screened at various concentrations of tyramine (dashed gray line). Data analyzed using GraphPad Prism ECanything (F ¼ 50 or EC 50 ). Table 1 EC 50 of tyramine and octopamine. This table shows the EC 50 for the concentrationdependent response of tyramine. The values were obtained when an R. microplus tyramine receptor and the Ga qi(5) G-protein chimera were transiently and stably transfected in CHO cells. Tyramine's activation of the receptor resulted in the increase of intracellular calcium concentration, which was measured using a calciumsensitive fluorescent dye. EC 50 ± SEM 95% CI Tyramine (transient) 9 ± 0.9 nM (0.1 nM, 764 nM) Octopamine (transient) 351 ± 2 nM (302 nM, 1476 nM) Tyramine (stable) 15 ± 7 nM (5 nM, 60 nM) Fig. 3 . Effect of biogenic amines against RmTAR1. Several biogenic amines were examined to determine if they activated the expressed receptor and increased the intracellular concentration of calcium by using a calcium-sensitive fluorescent dye that was measured in relative fluorescence units (RFU). Two-way ANOVA (a ¼ 0.05) different letters indicate a significant difference. concentrations of tyramine (Fig. 6) . Clonidine, naphazoline and tolazoline did not significantly agonize RmTAR1 to the same level as tyramine (Fig. 6 ). Naphazoline and tolazoline were able to partially agonize RmTAR1 at 10 mM, just not as strongly as tyramine itself.
Clonidine, naphazoline and tolazoline were also screened as antagonists or modulators of the tyramine receptor. This was performed by preincubating these compounds for 30 min prior to the addition of 150 nM tyramine. Tolazoline and naphazoline significantly enhanced the 150 nM response of tyramine at all three concentrations (0.1 mM, 1 mM and 10 mM), as shown in Fig. 7 .
Previously, this putative tyramine receptor had been hypothesized to be involved in resistance to the chemical acaricide amitraz, which is a formamidine insecticide/acaricide. Amitraz's metabolite, BTS-27271, was screened at 10 mM and 100 mM and significantly increased the150 nM-tyramine response by 191 ± 16% and 150 ± 24%, respectively. This agonistic activity was only observed in the presence of 150 nM tyramine (Fig. 8) .
Discussion
Reintroduction of R. microplus into the United States would have devastating consequences to the livestock industry. To aid in an integrative chemical approach to controlling the southern cattle (5) G-protein chimera. Antagonists were pre-incubated for 30 min prior to the addition of tyramine, which was added at 150 nM. The effect of the antagonist was normalized to this 150 nM tyramine response (100%, dashed line). Data was analyzed using a oneway ANOVA (a ¼ 0.05). An asterisk indicates a statistically significant antagonistic effect, compared to the addition of150 nM tyramine alone. tick, research is required to understand mechanisms of acaricide resistance, and to identify new chemistries that either target known mechanisms of action or identify new mechanisms of toxic action. The results shown here indicate that nucleic acid sequence originally thought to code for an octopamine receptor from R. microplus is actually a tyramine receptor. Additionally, functional assays showed that when this tyramine receptor was co-expressed with the Ga qi(5) chimera it resulted in the most significant response. The Ga qi(5) uses the Ga i receptor interacting domain; it is likely that this tyramine receptor would signal down the pathway that has an inhibitory effect on adenylate cyclase, thereby, decreasing the intracellular concentration of cAMP. Recent reviews have hypothesized, based on sequence data, that this receptor is a TAR1 (this class was previously known as octopamine/tyramine or tyramine receptor), which would normally signal through the Ga i pathway (Ohta and Ozoe, 2014; Verlinden et al., 2010; Farooqui, 2012) . Several TAR1 receptors have been identified and second messenger pathways analyzed from Apis mellifera, AJ245824 (Blenau et al., 2000) , Bombyx mori, AB162828 (Ohta et al., 2003) , Chilo Suppressalis, JQ416145 (Wu et al., 2013) , Drosophila melanogaster, X54794 (Saudou et al., 1990) , Heliothis virescens, X95606 (von Nickisch-Rosenegk et al., 1996) , Locusta migratoria, X69520 (Vanden Broeck et al., 1995) and Periplaneta americana, AM990461 (Rotte et al., 2009 ).
Pharmacological characterization of tyramine receptors, like octopamine receptors, is performed with agonists and antagonists used for the mammalian adrenergic system. Yohimbine is a known a 2 -adrenergic antagonist, and has previously been shown to be effective at blocking the inhibitory effect of tyramine on forskolinstimulated cAMP in heterologous expression systems (Ohta et al., 2003; Rotte et al., 2009; Wu et al., 2013) . Rotte et al. (2009) found that yohimbine produced the strongest antagonistic effect, followed by chlorpromazine then cyproheptadine. However, we find that yohimbine and cyproheptadine produce the strongest antagonistic effect, at the three tested concentrations, followed by mianserin (significant antagonism at 1 mM and 10 mM), then followed by phentolamine (significant at 10 mM). Phentolamine is widely accepted as a more efficient antagonist for octopamine receptors than for tyramine receptors (Roeder, 2005) , which is consistent with our results.
The tyramine receptor described here was also investigated for its potential role in amitraz resistance observed in southern cattle tick populations from Australia and the Americas (Baxter and Barker, 1999; Chen et al., 2007) . The first identification of the tyramine receptor was in Australia, and no point mutations were discovered in the amitraz-resistant strain compared to the amitraz-susceptible strain (Baxter and Barker, 1999) . However, the Santa Luiza and San Alfonso strains of southern cattle tick display two point mutations (T8P and L22S), and these ticks are resistant to amitraz . This was hypothesized to have a role in formamidine resistance, and this is currently the topic of ongoing studies in our laboratory. Recent studies have reinstated the Australian Rhipicephalus tick as a separate species, Rhipicephalus (Boophilus) australis (Fuller, 1899) present in Australia, Southeast Asia and Indonesia (EstradaPeña et al., 2012 Burger et al. 2014) . Separation of the Australian and American ticks into separate species suggests potential differences in mechanisms for development of amitraz resistance between the two species as it has been documented for pyrethroid resistance (Guerrero et al., 2014) .
Octopamine receptor(s) are believed to be the primary target of formamidine metabolites, including amitraz's metabolite BTS-27271. Demethylchlordimeform (chlordimeform's metabolite) did not have an effect on forskolin-stimulated cAMP on B. mori's tyramine receptor when expressed in HEK-293 cells (Ozoe et al., 2004) . We also did not see any effect of amitraz's metabolite alone (data not shown); however, significant receptor activation was observed when applied in combination with 150 nM tyramine (Fig. 7) . This indicates that BTS-27271 can have an effect at the tyramine receptor but probably only when the tyramine receptor is activated. Given the emerging evidence that populations around the world may constitute a species complex, having an understanding of amitraz-resistance may aid in adapting strategies to control of southern cattle ticks. Recently, a mutation in a putative R. microplus b-adrenergic-like octopamine receptor has been hypothesized to have a role in amitraz-resistance (Corley et al., 2013) . However, functional receptor and functional resistance assays have not been conducted against this octopamine receptor to date.
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